Here’s our fortnightly wrap of all the news driving ASX healthcare stocks.

It’s been a rough two weeks for small-cap life sciences investors, with 70 of the 132 companies in our list posting declines and just 42 gaining ground. Another 20 were flat.
 

The latest price performance for ASX-listed healthcare stocks:

Scroll or swipe to reveal table. Click headings to sort.

Code Company Price % return since Jan 20 %YTD return % return since 31/12/19 MktCap
ONT 1300 Smiles 682 .3 1.3 15.8 $161,486,579
1ST 1St Group 3.2 -3.0 -5.9 -59.0 $13,163,124
4DX 4Dmedical 208 -11.9 -14.4 $374,338,657
ACR Acrux 19 2.7 15.2 .0 $23,836,183
ACW Actinogen Medical 2 -4.8 -4.8 -43.3 $40,103,997
1AD Adalta 12.5 -13.8 .0 9.7 $27,564,956
ADR Adherium 2.1 -16.0 -25.0 -25.0 $30,646,982
ALC Alcidion Group 22 18.9 18.9 18.9 $13,591,920
AMT Allegra Orthopaedics 33.5 4.7 -4.3 67.5 $208,045,751
ATH Alterity Therap 3.5 .0 12.9 75.0 $34,993,833
AGH Althea Group 47 2.2 8.0 25.3 $69,052,299
ATX Amplia Therapeutics 27 -5.3 12.5 335.7 $119,379,961
ALT Analytica 0.35 16.7 16.7 16.7 $28,006,998
ADO Anteotech 16 39.1 52.4 642.7 $12,318,643
ANP Antisense Therapeut. 19 -19.1 46.2 111.1 $187,014,670
APH AP Hemp 44.5 -7.3 30.9 147.2 $103,330,069
AHK Ark Mines 3.4 .0 .0 .0 $1,778,920
ARX Aroa Biosurgery 121.5 8.5 5.7 $330,799,055
AT1 Atomo Diagnostics 29.5 .0 -3.3 $116,248,746
AC8 Auscann Grp Hlgs 18 -2.7 -7.7 -33.3 $55,483,287
AHC Austco Healthcare 10 5.3 1.0 8.7 $31,260,785
AVE Avecho Biotech 2.6 13.0 -10.3 550.0 $39,972,367
BD1 Bard1 Life Sciences 57 -2.6 -16.2 -44.1 $99,220,054
BNO Bionomics 15 .0 3.4 104.0 $563,757,752
BIT Biotron 7.3 -7.6 -6.4 40.4 $45,895,219
BXN Bioxyne 1.2 9.1 .0 -14.3 $110,287,133
BOT Botanix Pharma 17.25 19.0 38.0 110.4 $51,943,021
BPH BPH Energy 20.5 318.4 376.7 2263.7 $7,041,599
BWX BWX 408 .2 -.7 -7.6 $141,105,601
CAN Cann Group 65.5 -1.5 11.0 4.0 $170,340,592
CP1 Cannpal Animal 18 .0 5.9 50.0 $16,762,500
CAJ Capitol Health 29 3.6 5.5 33.3 $292,153,432
CDX Cardiex 7.9 -28.2 41.1 182.1 $73,949,372
CDY Cellmid 10.5 -4.5 -4.5 -52.3 $12,721,230
CHM Chimeric Therapeutic 30.5 -20.8 $61,897,500
CGS Cogstate 118.5 16.2 7.7 203.8 $192,369,314
CMP Compumedics 48 11.6 -4.0 -40.0 $81,494,956
CBL Control Bionics 80 -4.8 -14.9 $40,189,636
CPH Creso Pharma 21.5 -6.5 19.4 72.0 $192,485,146
CTE Cryosite 40 -7.0 1.3 654.7 $18,743,825
CYC Cyclopharm 275 -6.5 10.0 133.9 $250,649,263
CYP Cynata Therapeutics 67.5 -3.6 -1.5 -34.9 $93,129,786
DXB Dimerix 29 .0 23.4 123.1 $57,383,546
DOC Doctor Care Anywhere 129.5 -6.8 7.9 $231,855,076
DVL Dorsavi 3.4 -15.0 -17.1 36.8 $10,245,728
EXL Elixinol Global 20 5.3 14.3 -59.0 $57,971,642
FFC Farmaforce 9 .0 .0 -10.0 $11,589,388
GSS Genetic Signatures 185.5 -2.4 -7.7 80.1 $268,604,522
GTG Genetic Technologies 1 11.1 33.3 81.8 $90,117,267
GLH Global Health 42.5 -1.2 -9.6 193.1 $17,891,786
HXL Hexima 16.5 .0 -10.8 -45.9 $19,259,585
HCT Holista CollTech 7.1 1.4 -1.4 -10.1 $19,549,785
ICS ICSGlobal 196 .5 -7.1 4.6 $20,627,077
IDT IDT Australia 19.5 2.6 5.4 39.3 $48,856,556
IBX Imagion Biosys 17.5 .0 20.7 649.4 $171,645,944
IMC Immuron 21.5 -6.5 -6.5 65.4 $47,635,876
IMM Immutep 40 -5.9 -3.6 53.8 $262,733,741
IPD Impedimed 11.5 -4.2 -8.0 -27.8 $138,076,953
IMU Imugene 9.8 -6.7 -2.0 206.3 $475,111,142
IHL annex Healthcare 16.5 .0 6.5 166.1 $171,929,506
ICR Intelicare Holdings 26 10.6 8.3 $10,453,869
IVX Invion 0.9 -5.3 -10.0 -30.8 $55,377,923
JHC Japara Healthcare Lt 69.5 .0 12.1 -27.4 $183,064,420
JHL Jayex Healthcare 4 -4.8 2.6 33.3 $8,255,884
KZA Kazia Therapeutics 128 -2.3 10.3 122.6 $153,292,011
LBT LBT Innovations 10.5 -8.7 -14.3 -34.4 $30,357,092
LSH Lifespot Health 11.5 -17.9 49.4 248.4 $19,373,700
LCT Living Cell Tech. 1.5 -16.7 7.1 -6.3 $8,571,615
M7T Mach7 Tech 147 21.0 17.6 117.6 $26,444,708
MDR Medadvisor 37 8.8 4.2 4.3 $347,382,220
MEB Medibio 0.9 -18.2 12.5 -7.4 $131,209,166
MVP Medical Developments 656 -3.8 -1.8 -24.8 $12,128,963
MDC Medlab Clinical 31.5 -12.5 31.3 3.3 $466,783,602
MEM Memphasys 10.5 .0 5.0 110.0 $83,902,701
MXC Mgc Pharmaceuticals 2.6 .0 4.0 -18.8 $83,025,127
MX1 Micro-X 35.5 -4.1 .0 80.9 $46,491,389
MMJ MMJ Group Hlds 12 -9.4 -4.0 -17.2 $125,808,115
MVF Monash IVF Group 78 5.4 -.6 -17.3 $292,226,130
NC6 Nanollose 14.5 -23.7 168.5 220.5 $16,085,128
NEU Neuren Pharmaceut. 149.5 1.4 16.3 -39.7 $156,440,067
NSB Neuroscientific 22.5 -6.3 -10.0 18.4 $19,900,038
NTI Neurotech Intl 5 .0 11.1 212.5 $23,563,501
NXS Next Science 118 1.7 -5.6 -37.2 $144,410,786
EYE Nova EYE Medical 33 -1.5 -7.0 -17.6 $47,416,426
NOX Noxopharm 69.5 26.4 41.8 181.1 $182,087,716
NYR Nyrada . 36 -4.0 50.0 $29,018,613
OSL Oncosil Medical 12 -7.7 .0 -28.0 $100,917,912
ONE Oneview Healthcare 8 77.8 77.8 -24.8 $27,868,416
OPT Opthea 192.5 -6.6 .3 -35.4 $648,315,204
OIL Optiscan Imaging 10.5 -16.0 .0 176.3 $65,640,333
OCC Orthocell 53 5.0 17.8 8.2 $99,097,678
OSP Osprey Med 2.1 -4.5 -4.5 -30.0 $34,090,286
OSX Osteopore 49.5 -1.0 -4.8 -32.2 $39,018,900
OVN Oventus Medical 21.5 -14.0 -8.5 -56.1 $32,443,795
PSQ Pacific Smiles Grp 260 -1.1 2.0 47.6 $443,929,654
PCK Pahek 7 .0 -9.1 -63.2 $397,605,275
PAL Palla Pharma 62 -10.1 -23.5 -41.2 $76,622,726
PAR Paradigm Bio. 276 12.2 8.2 -5.8 $78,087,746
PGC Paragon Care 24 6.7 6.7 -45.5 $562,377,825
PAB Patrys 2.7 -6.9 12.5 35.9 $81,092,470
PAA Pharmaust 10 3.1 -4.8 -7.0 $48,815,343
PXS Pharmaxis 8.8 -5.4 -5.4 -45.0 $31,672,992
PNV Polynovo 262 -1.5 -32.5 33.0 $34,554,642
PTX Prescient 10.5 26.5 56.7 72.1 $1,745,272,436
PBP Probiotec 221 -9.1 -7.9 13.9 $70,460,831
PIQ Proteomics Int Lab 74 .0 -6.9 174.1 $179,681,200
PYC PYC Therapeutics 13.5 -10.0 -8.5 119.4 $77,630,348
RAC Race Oncology 211 24.9 20.6 1010.5 $239,498,919
RCE Recce Pharmaceutical 103 -2.4 -2.4 186.1 $182,416,054
RGS Regeneus 11 -8.3 -12.0 26.4 $33,031,282
RAP Resapp Health 6.7 -16.3 -21.2 -72.7 $51,552,125
RHT Resonance Health 18.5 -5.1 -22.9 -17.8 $80,748,357
RSH Respiri 12 -7.7 -7.7 25.0 $90,292,599
RNO Rhinomed 15.5 19.2 -3.1 -26.2 $32,995,187
RHY Rhythm Biosciences 122 -9.0 39.4 972.5 $242,802,452
SDI SDI 79 5.3 .6 -3.2 $93,903,769
SVA Simavita 1.6 .0 .0 -36.0 $23,671,965
SOM SomnoMed 185.5 -4.9 -11.7 -26.3 $152,690,936
S66 Star Combo 30 .0 -9.1 -38.1 $40,413,741
SCU Stemcell United 1.65 3.1 -13.2 17.9 $13,445,131
SUD Suda Pharmaceuticals 4.6 9.5 15.0 -6.4 $17,259,519
TD1 Tali Digital 4.1 -12.8 -12.8 -19.6 $43,575,098
TLX Telix Pharmaceutical 424.5 -5.0 12.3 173.9 $33,244,232
THC THC Global Grp 24 2.1 2.1 -36.8 $1,155,269,927
TRU Truscreen 11.5 -8.0 $43,543,950
UBI Universal Biosensors 48 .0 10.3 152.6 $81,663,893
VBS Vectus Biosystems 133 .0 10.8 125.4 $42,101,674
VTI Vision Tech, 1.7 -10.5 -32.0 -67.3 $17,887,060
VLS Vita Life Sciences.. 95 -1.0 -5.0 47.4 $51,378,481
VHT Volpara Health Tech 155.5 6.1 8.4 -15.0 $385,289,729
ZLD Zelira Therapeutics 7.85 -19.1 -14.7 42.7 $93,640,514
ZNO Zoono Group 99.5 -22.3 -24.3 62.7 $161,651,016

The biggest gainer by far has been nano-cap holding company BPH Energy (ASX:BPH), whose shares are up 318.4 per cent in the period from January 20 through to yesterday afternoon.

BPH is working on commercialising a device “that measures a patient’s brain electrical activity (EEG) to indicate the response to drugs administered during surgery”. But handily, it’s also into oil and gas exploration.

In response to an ASX price query January 25, BPH pointed mostly to progress by Advent Energy, which BPH has a 26 per cent stake in, in obtaining an offshore petroleum licence as a reason for the price spike.

Oneview Healthcare (ASX:ONE) has gained 77.8 per cent to 8c after signing a distribution agreement with Samsung to deliver bedside digital services for patients in the United States.

Anteotech (ASX:ADO) has risen 39.1 per cent over the fortnight – and was up 85 per cent yesterday – after its customer Ellume gained a $US232 million ($302 million) US contract for COVID-19 tests. White House officials announced the contract on Monday.

On the flip side, CardieX (ASX:CDX) was the biggest loser over the fortnight, with its shares declining 28.2 per cent following an unexplained price spike.  CDX shares are still up 41 per cent since the start of the year, however.

So far this year, Nanollose (ASX:NC6) is the biggest gainer, with a 168.5 per cent rise after the ecofibre company and a partner filed a patent for a plant-based rayon fabric.

BPH is also the biggest gainer since the start of 2020 – its shares are up more than twentyfold since that time, from 0.1c to 21c.

Race Oncology (ASX:RAC) is in second, with its shares climbing just over elevenfold in the 13-month span.